Treatment with 13-cis-retinoic acid in transfusion-dependent patients with myelodysplastic syndrome and decreased toxicity with addition of alpha-tocopherol.

Besa, E C; Abrahm, J L; Bartholomew, M J; Hyzinski, M; Nowell, P C

Besa, E C; Abrahm, J L; Bartholomew, M J; Hyzinski, M; Nowell, P C.

Affiliation

Besa EC; Department of Medicine, Medical College of Pennsylvania, Philadelphia 19129.

Am J Med ; 89(6): 739-47, 1990 Dec.

Article in En | MEDLINE | ID: mdl-2252043

Subject(s)

Blood Transfusion; Isotretinoin/therapeutic use; Myelodysplastic Syndromes/drug therapy; Vitamin E/therapeutic use; Adult; Aged; Aged, 80 and over; Bone Marrow/pathology; Drug Combinations; Drug Interactions; Female; Humans; Isotretinoin/administration & dosage; Isotretinoin/toxicity; Karyotyping; Male; Middle Aged; Remission Induction; Survival Analysis; Time Factors; Vitamin E/administration & dosage; Vitamin E/pharmacology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vitamin E / Blood Transfusion / Myelodysplastic Syndromes / Isotretinoin Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Am J Med Year: 1990 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links